| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/19/1999 | US5861387 Treatment and prevention of breast and endometrial cancer, bone loss, and for treating endometriosis |
| 01/19/1999 | US5861381 Pharmaceutical composition for the treatment of a malignant tumor |
| 01/19/1999 | US5861377 Antistasin type serine protease inhibitors |
| 01/19/1999 | US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes |
| 01/19/1999 | US5861307 Liposomes embedded with dna; antitumor agents; apotosis |
| 01/19/1999 | US5861290 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders |
| 01/19/1999 | US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto |
| 01/19/1999 | US5861170 Acetylsalicyclic acid-containing transdermal application system for antithrombotic therapy |
| 01/19/1999 | US5861159 Controlled release of pharmaceutically active substances for immunotherapy |
| 01/19/1999 | US5861158 Improving a transplantation of hematopoietic cells from a donor to a recipient |
| 01/19/1999 | US5861156 Methods of delivering agents to target cells |
| 01/19/1999 | CA2215339C Immunomodulating compositions from bile for the treatment of immune system disorders |
| 01/19/1999 | CA2179987C Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine |
| 01/19/1999 | CA2089820C Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates |
| 01/19/1999 | CA1340322C Human papillomavirus type 41, its dna and the proteins encoded therefrom |
| 01/15/1999 | CA2220849A1 A human pelota homolog |
| 01/14/1999 | WO1999001764A2 METHOD FOR DETERMINING GnRH RECEPTORS |
| 01/14/1999 | WO1999001579A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 01/14/1999 | WO1999001541A1 IKK-α PROTEINS, NUCLEIC ACIDS AND METHODS |
| 01/14/1999 | WO1999001472A1 Cyclic azapeptides with angiogenic effect |
| 01/14/1999 | WO1999001466A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1999001456A1 Synthesis of and intermediates for camptothecins |
| 01/14/1999 | WO1999001434A1 Inhibitors of farnesyl protein transferase |
| 01/14/1999 | WO1999001426A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001421A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | WO1999001123A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | WO1999001118A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 01/14/1999 | WO1999001117A2 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 01/14/1999 | WO1998044096A3 Mycobacterium recombinant vaccines |
| 01/14/1999 | WO1998042729A3 Steroid sulfamates, method for the production and use thereof |
| 01/14/1999 | WO1998034952A3 Il-2 gene expression and delivery systems and uses |
| 01/14/1999 | WO1998021333A3 Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
| 01/14/1999 | DE19830167A1 New aza:tyrosine derivatives |
| 01/14/1999 | CA2297181A1 Cyclic azapeptides |
| 01/14/1999 | CA2295294A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | CA2295212A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | CA2294988A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 01/14/1999 | CA2294785A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | CA2294764A1 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 01/14/1999 | CA2294530A1 Inhibitors of farnesyl protein transferase |
| 01/14/1999 | CA2290509A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | CA2236489A1 Novel compounds |
| 01/13/1999 | EP0890361A1 Antitumor agent |
| 01/13/1999 | EP0889972A1 Diagnostic method and apparatus |
| 01/13/1999 | EP0889971A1 Phosphatase modulator |
| 01/13/1999 | EP0889969A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 01/13/1999 | EP0889961A2 Monocyte chemotactic protein-5 materials and methods |
| 01/13/1999 | EP0889905A1 Cytokine antagonists and agonists |
| 01/13/1999 | EP0889900A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 01/13/1999 | EP0889898A1 Morpholinyl anthracycline derivatives |
| 01/13/1999 | EP0889878A1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors |
| 01/13/1999 | EP0889877A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
| 01/13/1999 | EP0889876A1 Meta-substituted phenylene sulphonamide derivatives |
| 01/13/1999 | EP0889875A1 Cyclopropyl alkanoic acid derivatives |
| 01/13/1999 | EP0889734A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof |
| 01/13/1999 | CN1204530A Method for preparing anti-tumour Chinese medicinal liquor |
| 01/13/1999 | CN1204522A Chinese prescription medicine for treatment of digestive tract tumour and preparation method thereof |
| 01/13/1999 | CN1204521A Tumour eliminating and analgesic adhesive plaster and its preparation method |
| 01/13/1999 | CN1204511A Anticancer medicine and preparation technology thereof |
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859253 Metalloproteinase inhibitors |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5859062 Guanylhydrazones and their use to treat inflammatory conditions |
| 01/12/1999 | US5859061 Matrix metalloproteinase inhibitors; treating diseases involving connective tissue degradation |
| 01/12/1999 | US5859054 Leukotriene B4 derivatives, process for their production and their use as pharmaceutical agents |
| 01/12/1999 | US5859047 Antiarthritic agents, nervous system disorders |
| 01/12/1999 | US5859036 Antiinflammatory agents, analgesics |
| 01/12/1999 | US5859021 Antiviral combinations |
| 01/12/1999 | US5859015 N-heterocyclic piperazinyl and H-heterocyclic piperazinonyl inhibitors of farnesyl-protein transferase |
| 01/12/1999 | US5859013 Method for inducing death of neoplastic cells using piperazine derivatives |
| 01/12/1999 | US5859012 Inhibitors of farnesyl-protein transferase |
| 01/12/1999 | US5858994 Carbohydrate conjugates as inhibitors of cell adhesion |
| 01/12/1999 | US5858784 Aerosol transfecting agent |
| 01/12/1999 | US5858780 Cisplatin resistant cell line |
| 01/12/1999 | US5858758 Human serine protease precursor |
| 01/12/1999 | US5858744 Gene transfer into stem cells |
| 01/12/1999 | US5858719 Polynucleotides encoding human ATP binding-cassette transport protein and methods of use |
| 01/12/1999 | US5858716 H2CAA71 polynucleotides |
| 01/12/1999 | US5858715 Polynucleotide sequence for antisense agents, hybridization probes and diagnosis of diseases; anticancer agents; antiischemic agents; alzheimer's/parkinson's diseases |
| 01/12/1999 | US5858710 Tumor-associated kazal inhibitor-like polypeptides and encoding polynucleotides |
| 01/12/1999 | US5858708 For genetically engineered expression vectors in host cells, antisense molecules, and diagnosis and treatment of nervous system degenerative disorders such as amyotrophic lateral sclerosis |
| 01/12/1999 | US5858683 Determining presence of non-chromatin protein in biological sample (pap smears) by immunoassay or two-dimensional electrophoresis; accurate rapid diagnosis before metastasis occurs |
| 01/12/1999 | US5858674 Screening assays to identify agents that modulate cisplatin resistance |
| 01/12/1999 | US5858365 Administering butyric acid and an amino acid, heptafluorobutyric acid, 3-chloropropionic acid, beta-chloro-l-alanine hydrochloride and isobutyramide for ulcers |
| 01/12/1999 | US5858361 Monoclonal anti-idiotypic anti-CA125 antibodies and pharmaceutical compositions containing them |
| 01/12/1999 | CA2138122C Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach and breast cancer |
| 01/07/1999 | WO1999000518A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 01/07/1999 | WO1999000507A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | WO1999000498A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | WO1999000421A1 Site-directed chemotherapy of metastases |
| 01/07/1999 | WO1999000420A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | WO1999000404A1 Secreted proteins |
| 01/07/1999 | WO1999000399A1 Method of producing tiazofurin and other c-nucleosides |
| 01/07/1999 | WO1999000381A1 Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them |
| 01/07/1999 | WO1999000353A1 Novel thyroid receptor ligands and method |
| 01/07/1999 | WO1999000137A2 Induction of an activated myeloid dendritic cell phenotype |
| 01/07/1999 | WO1999000116A2 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/07/1999 | WO1999000113A1 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 01/07/1999 | WO1998046270A3 Polymeric conjugates polyvalently presenting an agent for therapy |